RxDoctor Payments Data

Taelor Baetz, PA

Physician Assistant · Ponca City, OKNPI 1881385656

Payments from drug & device makers

$1,417in general payments, 2019–2025

Across 69 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$358
  • Regeneron Healthcare Solutions, Inc.$164
  • Sanofi$132
  • Boehringer Ingelheim$128
  • Actelion Pharmaceuticals US, Inc.$110
  • GSK$99
  • plus $428 from 15 others

What the payments were for

  • Food & beverage$1,417100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,417 in reported general payments places this provider in the 75th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$15,715
Medicare patients
126
Services billed
408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter172$218,452
Breztri AerosphereBudesonide/Glycopyr/Formoterol67$80,311
Dupixent SyringeDupilumab12$44,137
Breo ElliptaFluticasone/Vilanterol27$14,973
Tadalafil15$11,658
XareltoRivaroxaban12$9,119
Combivent RespimatIpratropium/Albuterol Sulfate12$7,898
Bevespi AerosphereGlycopyrrolate/Formoterol Fum14$6,883
SymbicortBudesonide/Formoterol Fumarate19$6,410
Zafirlukast41$5,913
Incruse ElliptaUmeclidinium Bromide13$5,891
Albuterol Sulfate HfaAlbuterol Sulfate164$5,027
Ventolin HfaAlbuterol Sulfate46$3,850
Montelukast Sodium252$2,602
Doxepin Hcl12$2,524

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$99$239,316212 claims
AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort$358$93,604100 claims
Boehringer IngelheimCombivent Respimat$128$7,89812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Ponca City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →